Robeco Institutional Asset Management’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20,619
Closed -$2.2M 863
2025
Q2
$2.2M Sell
20,619
-56,916
-73% -$5.75M ﹤0.01% 669
2025
Q1
$7.06M Sell
77,535
-23,873
-24% -$2.67M 0.01% 486
2024
Q4
$11.6M Sell
101,408
-13,644
-12% -$1.56M 0.02% 423
2024
Q3
$13.7M Sell
115,052
-23,582
-17% -$2.17M 0.03% 394
2024
Q2
$11.1M Sell
138,634
-2,275
-2% -$208K 0.02% 407
2024
Q1
$13M Buy
140,909
+8,693
+7% +$834K 0.03% 398
2023
Q4
$14M Sell
132,216
-4,168
-3% -$420K 0.03% 388
2023
Q3
$14.8M Buy
136,384
+16,179
+13% +$1.79M 0.04% 367
2023
Q2
$13M Buy
120,205
+45,472
+61% +$5.11M 0.03% 388
2023
Q1
$9.31M Buy
74,733
+47,924
+179% +$6.58M 0.03% 447
2022
Q4
$4.03M Buy
+26,809
New +$4.13M 0.01% 598

Other funds holding BNTX

Robeco Institutional Asset Management's BNTX Position: Q3 2025 in Review

Robeco Institutional Asset Management sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 20,619 shares — an estimated $2.2M sold.

Robeco Institutional Asset Management first reported a position in BNTX in Q4 2022 and held it in 11 quarters. The position peaked at $14.8M in Q3 2023. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Robeco Institutional Asset Management reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 20,619 BioNTech shares in Q3 2025, an estimated $2.2M.
  • Robeco Institutional Asset Management first reported a position in BioNTech in Q4 2022 and held it in 11 quarters.
  • Robeco Institutional Asset Management's BioNTech position peaked at $14.8M in Q3 2023.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2025, filed 22 Oct 2025.